Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 CordenPharma Completes SafeBridge Recertification | Contract Pharma

What are you searching for?

Sign in
Breaking News

CordenPharma Completes SafeBridge Recertification

Potent Compound Recertification Audit was conducted at Colorado site

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

CordenPharma Colorado has successfully completed the Potent Compound Recertification Audit by SafeBridge Consultants. Certification has been maintained since first awarded in 2013.
 
The onsite assessment included the evaluation of physical plant features, programs, exposure controls, procedures and practices applied towards the manufacturing of highly potent active pharmaceutical ingredients (APIs), consisting of a review of over 60 elements.
 
By meeting the criteria established under the SafeBridge program, CordenPharma Colorado is deemed competent and proficient in the safe handling of potent APIs and compounds.
 
“Containment of highly potent compounds is a multi-faceted endeavor that goes far beyond the installation of good containment equipment,” said Robin Livingston, manager, environmental, health and safety, CordenPharma Colorado. “The strength of our containment program is demonstrated by our approach from all directions, including engineering controls, a containment culture, process development, occupational health pre-planning, and an ongoing containment execution cycle.”
 
Jason Bertola, director, global highly potent and oncology platform, CordenPharma International, said, “CordenPharma Colorado has a long and successful history in manufacturing highly potent APIs, with robust processes in place to handle compounds well below 50ng/m3 OEL. SafeBridge’s recertification provides objective and scientifically supported assessment further validating our capabilities to support customers with any challenge they bring our way.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics